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Summary
Over 40humandiseasesareassociatedwith the forma-
tion of well-defined proteinaceous fibrillar aggregates.
Since the oligomers precursors to the fibrils are in-
creasingly recognized to be the causative agents of
such diseases, it is important to elucidate the mecha-
nismof formationof theseearly species. Theacylphos-
phatase from Sulfolobus solfataricus is an ideal sys-
tem as it was found to form, under conditions in
which it is initially native, two types of prefibrillar
aggregates: (1) initial enzymatically active aggregates
and (2) oligomers with characteristics reminiscent of
amyloid protofibrils, with the latter originating from
the structural reorganization of the initial assemblies.
By studying a number of protein variants with a variety
of biophysical techniques, we have identified the
regions of the sequence and the driving forces that
promote the first aggregation phase and show that
thesecondphaseconsists inacooperative conversion
involving the entire globular fold.
Introduction
Proteins and peptides have a generic tendency to con-
vert from their soluble states into well-organized aggre-
gates such as extracellular amyloid fibrils or intracellular
inclusions with amyloid-like characteristics (Uversky
and Fink, 2004; Chiti and Dobson, 2006). This intrinsic
tendency can also be seen in the ability of proteins
that have no link to human diseases to form amyloid-
like fibrils under appropriate conditions in vitro (Stefani
and Dobson, 2003; Uversky and Fink, 2004). Since these
aggregates are toxic to the cells, especially in the form of
early-forming oligomers and/or amyloid protofibrils, this
essential behavior of polypeptide chains represents
a constant challenge for every living organism (Buccian-
*Correspondence: fabrizio.chiti@unifi.ittini et al., 2002). It was suggested that protein sequences
and the cellular machinery have evolved, among other
requirements, to inhibit uncontrolled protein aggrega-
tion (Dobson, 2003). Failure of the cell’s defense mech-
anisms against protein aggregation often results in pa-
thology. To date, over 40 human diseases, including
Alzheimer’s, Parkinson’s, Creutzfeldt-Jacob’s disease,
and type II diabetes have been shown to be associated
with the formation of amyloid fibrils or intracellular inclu-
sions with amyloid-like properties (Chiti and Dobson,
2006). Interestingly, in addition to its involvement in cel-
lular housekeeping and disease, amyloid fibril formation
is also exploited by living organisms for the formation
of fibrillar structures with specific biological functions,
provided that this occurs under controlled conditions
(Chapman et al., 2002; Chiti and Dobson, 2006). Per-
haps, the most fascinating of these biological functions
is the ability of such structures to serve as transmissible
genetic traits distinct from DNA genes (Chien et al.,
2004).
Concerning the detrimental features of the aggregated
structures, there is an increasing consensus that pre-
fibrillar aggregates, rather than mature fibrils, represent
the pathogenic species, at least in some protein deposi-
tion diseases (Walsh and Selkoe, 2004). Consequently,
the cell needs to constantly repress the formation of
these pathological agents. Moreover, although some
proteins that adopt a well-defined three-dimensional
conformation under physiological conditions generally
aggregate following partial unfolding, it has recently
been found that some other folded proteins can aggre-
gate following pathways in which unfolding is not the first
step in this complex process (Bouchard et al., 2000; Ped-
ersen et al., 2004; Plakoutsi et al., 2004). The observation
that all-b proteins have evolved structural adaptations to
prevent their aggregation via interaction of their native
b sheets suggests that native-like aggregation is indeed
a constant and plausible danger in the highly crowded
environments of living organisms where proteins spend
most of their lifetime in a folded conformation (Richard-
son and Richardson, 2001). Prion proteins such as
HET-s from P. anserina and Ure2p from S. cerevisiae
are suggested to be able to form amyloid-like fibrils in
which the folded units retain in each case native-like con-
formations (Bousset et al., 2002; Balguerie et al., 2003;
Baxa et al., 2003). Following these emerging themes, it
becomes important to investigate the mechanism of for-
mation of potentially toxic oligomers under conditions in
which globular proteins adopt initially a native-like folded
conformation prior to aggregation.
One particularly favorable system with which to study
the formation of prefibrillar aggregates under such con-
ditions is the acylphosphatase from Sulfolobus solfatar-
icus (Sso AcP). This a/b 101 residue protein is character-
ized, by contrast with the other acylphosphatases so far
investigated, by an 11 residue unstructured segment at
the N terminus (Corazza et al., 2006) (Figure 1). Sso
AcP forms stable amyloid-like protofibrils under condi-
tions in which the protein is initially folded (Plakoutsi
et al., 2004). This occurs via an exponential phase in the
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994absence of any detectable lag phase. Although proto-
fibril formation also occurs in the absence of added de-
naturants (Plakoutsi et al., 2004), solutions containing
15%–25% trifluoroethanol (TFE) are generally preferred
as these conditions allow protofibril formation to occur
more rapidly, on a time scale that is reasonable for lab
experiments, while maintaining the protein in a folded
conformation prior to aggregation (Plakoutsi et al., 2005).
It has been shown that in 20% (v/v) TFE (pH 5.5) 25ºC,
Sso AcP assembles initially, within 1–2 min, into aggre-
gates that (1) do not bind thioflavin T (ThT), Congo red
(CR), or 1-anilino-8-napthalenesulfonic acid (ANS); (2)
do not contain an extensive b-sheet structure; and (3)
retain considerable enzymatic activity (Plakoutsi et al.,
2005). In spite of the seemingly native topology, far-UV
circular dichroism (CD) and Fourier transform infrared
(FT-IR) spectroscopies indicate that subtle conforma-
tional changes are associated with the formation of these
species (Plakoutsi et al., 2005). These oligomers convert,
with no apparent need of disassembly and renucleation
and with a rate that is independent of protein concentra-
tion, into spherical aggregates that (1) possess a diame-
ter of 3–5 nm and assemble further to form chain-like
structures; (2) bind ThT, CR, and ANS; (3) possess exten-
sive b-sheet structure; and (4) do not retain enzymatic
activity (Plakoutsi et al., 2005). We will refer to the first
and second species as the ‘‘initial aggregates’’ and ‘‘am-
yloid protofibrils,’’ respectively. Interestingly, the two
processes occur with rates that are, correspondingly,
Figure 1. Three-Dimensional Structure of Sso AcP
The structure was determined by X-ray crystallography (Corazza
et al., 2006). The PDB entry is 2BJD. The structure determined by
NMR spectroscopy shows a similar topology (Corazza et al., 2006).
The N-terminal tail, devoid of a precise conformation, is added arbi-
trarily and has only a descriptive purpose. The regions of native Sso
AcP that are most exposed to the solvent and/or have a major flex-
ibility, as identified by limited proteolysis, are indicated in red.three and two orders of magnitude more rapid than Sso
AcP unfolding under the same conditions, indicating
that unfolding is not required to initiate this self-assem-
bly process. This has led to a mechanism of aggregation
that can be summarized with a simplified scheme of the
type N4 (N)n4 PF, where N is the monomeric folded
state, and (N)n and PF represent the initial aggregates
with native-like topology and the amyloid protofibrils, re-
spectively (Plakoutsi et al., 2005). Although PF can form
directly from N, the kinetic analysis shows that most
of the molecules transit through the initial aggregates
(Plakoutsi et al., 2005).
The driving forces and the mechanism, at a molecular
level, of this peculiar aggregation process remain to be
elucidated. By combining a number of experimental
approaches, we will identify the regions of the sequence
and the driving forces that promote the first aggregation
phase and show that the second phase consists in a co-
operative conversion involving the entire globular fold as
a whole, rather than specific regions of the sequence. We
will also emphasize that such an aggregation mecha-
nism is conceptually distinct from those proposed for
other globular proteins and for systems with prion-like
properties.
Results
The Unstructured N-Terminal Stretch Is Essential
for Aggregation of Sso AcP
The presence of an 11 residue unstructured tail at the
N terminus of native Sso AcP (Figure 1) prompted us to
investigate the role of this sequence segment in the
aggregation of the full-length protein. Three deletion mu-
tants were produced, lacking 5, 8, and 11 residues at the
N terminus (DN5, DN8, and DN11 Sso AcP, respectively).
The aggregation of the truncated variants was studied at
a protein concentration of 0.4 mg ml21 in 20% (v/v) TFE,
50 mM acetate buffer (pH 5.5), 25ºC, conditions under
which Sso AcP still adopts a folded structure prior to ag-
gregation (Plakoutsi et al., 2004). While the DN5 and DN8
variants of Sso AcP are still able to form the ThT binding
protofibrils, albeit with rates that appear progressively
slower upon truncation, the DN11 variant does not con-
vert into such aggregates even after prolonged exposure
to these conditions (Figure 2A).
The CD spectrum of theDN11 variant does not undergo
detectable changes following incubation of the mutant
under these conditions and remains similar to those of
native wild-type and native DN11 Sso AcP acquired at
pH 8.0 in the absence of TFE (Figure 2B). This spectrum
is readily distinguishable from those of the initial aggre-
gates and protofibrils that are recorded for the wild-
type and the other truncated variants during aggregation
(Figure 2B). The self-assembly of the native-like protein
into initial aggregates can be monitored by following
the mean residue ellipticity at 208 nm ([q]208), as the differ-
ence of the signal between the two conformational states
is maximal at this wavelength (Figure 2B). The increase of
[q]208 becomes progressively slower with the shortening
of the N-terminal tail, with the DN11 mutant maintaining
a stable native-like signal up to 4 hr (Figure 2C). The for-
mation of the initial aggregates can also be monitored ef-
fectively with light scattering, as this phase corresponds
to a rapid high-amplitude increase of the light scattering
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as the initial aggregates convert into protofibrils
(Plakoutsi et al., 2005). Neither increase nor decrease
was observed withDN11Sso AcP (Figure 2D).From these
data we conclude that the unstructured segment at the N
terminus is essential to promote formation of the initial
aggregates, and consequently of the amyloid protofibrils,
in the full-length Sso AcP.
The Isolated Unstructured Tail of Sso AcP
Does Not Aggregate
To assess whether the first step of Sso AcP aggregation
consists in the stacking of N-terminal tails, with the glob-
ular units remaining folded to decorate the core of such
assembled tails, an 11 residue peptide with a sequence
identical to the N-terminal tail of Sso AcP was synthe-
sized (sequence MKKWSDTEVFE). The lyophilized pep-
tide was suspended at concentrations ranging from 30 to
350 mM in the absence or presence of 20% (v/v) TFE for
30 min (50 mM acetate [pH 5.5], 25ºC). The peptide con-
centrations for the various samples, determined spec-
trophotometrically after filtration with 0.02 mm filters,
are in good agreement with the concentrations of the to-
tal peptide before filtration (Figure 3A). This indicates
that the peptide remained largely soluble in all samples,
even at molar concentrations ten times higher than those
used here to promote aggregation of the full-length pro-
tein. The high solubility of the peptide probably results
from the high number of polar charged residues present
in its sequence.
The size distributions acquired by dynamic light scat-
tering (DLS) show that the peptide has an apparent
Figure 2. Aggregation Kinetics of Sso AcP
The traces are reported as changes in the fluorescence intensity of
ThT at 485 nm (A), in far-UV CD spectra (B), in mean residue ellipticity
at 208 nm (C), and in light-scattering intensity during aggregation (D).
The kinetic traces in (A), (C), and (D) refer to the wild-type (black),
DN5 (red), DN8 (blue), and DN11 (green) Sso AcP. The ThT and light
scattering traces (A and D) were normalized to attribute 100% to the
maximum value. In all experiments, conditions were 0.4 mg ml21
protein, 20% (v/v) TFE, 50 mM acetate (pH 5.5) at 25ºC. The far-UV
CD spectra reported in (B) for native wild-type and native DN11
Sso AcP in 10 mM Tris (pH 8.0), 25ºC, are roughly superimposable
to those of DN11 Sso AcP incubated under aggregating conditions
in 20% TFE for 1 min, 10 min, and 4 hr. By contrast, the spectra of
the initial aggregates (2 min) and protofibrils (30 min) for wild-type
Sso AcP are distinct (dashed and dotted lines, respectively).hydrodynamic diameter of 1.5 6 0.3 and 1.95 6 0.5 in
0% and 20% (v/v) TFE, respectively (Figure 3B). These
values are within error to that expected for an 11 residue
peptide in its unstructured monomeric form, corre-
sponding to 1.85, 1.73, and 1.61 nm with the formulas
reported by three independent groups (Damaschun
et al., 1998; Wilkins et al., 1999; Kohn et al., 2005). Since
the intensity of the scattered light scales with the square
of the molecular mass of the light-scattering particle, the
species with diameters higher than 4 nm in the reported
size distributions are quantitatively irrelevant.
The far-UV CD spectra of the peptide samples in
0% and 20% (v/v) TFE have both a negative peak at
198–200 nm, indicating a largely unstructured conforma-
tion in both solution conditions (Figure 3C). The results
obtained with the solubility assay, DLS, and far-UV CD
were substantially similar when the experiments were
repeated with an extended 14 residue peptide (sequence
MKKWSDTEVFEMLK), corresponding to the first 14
residues of Sso AcP (data not shown). In summary, while
full-length Sso AcP aggregates under the investigated
conditions, neither the N-terminal tail nor the globular
unit can do so when separated from each other.
Native Sso AcP Has Portions of the Sequence
with a Preferential Flexibility
To map out the specific residues or regions of the se-
quence of Sso AcP that appear most exposed to the sol-
vent and/or flexible, and therefore available for intermo-
lecular interactions, a limited proteolysis approach was
used. Under the conditions used for these experiments
(pH 7.5 and 20 mM protein concentration), aggregation
was sufficiently slow in both the absence and presence
of TFE as to allow the folded monomeric full-length
form of the protein to be characterized. Size-exclusion
high-performance liquid chromatography (SE-HPLC)
confirmed that Sso AcP maintains a monomeric state in
all tested conditions over the time required for the com-
pletion of the experiment (data not shown). In the ab-
sence of TFE,sixproteases were usedwith theaim of cre-
ating conditions in which the selectivity of the cleavage
was not limited by the specificity of individual enzymes.
The proteases were trypsin, chymotrypsin, subtilisin,
elastase, endoprotease Glu-C, and thermolysin. The lat-
ter two were found to be inactive in the presence of
TFE, and the experiments were carried out with the four
remaining proteases. In each experiment, aliquots of 1
ml of the digestion mixture were withdrawn at different
time intervals and analyzed by matrix-assisted laser de-
sorption ionizationmassspectrometry (MALDI-MS) in lin-
ear mode, as described in the Experimental Procedures
section. Direct peptide analysis by MALDI-MS allowed
the extent of proteolytic digestions to be monitored on
a much shorter time scale with much fewer protein sam-
ples. Moreover, small peptide components could also be
detected due to the higher sensitivity of the massspectral
analysis. A proteolytic site between residues a and bwas
evaluated to occur on the full-length protein provided that
the two complementary fragments (from the N terminus
to a and from b to the C terminus) could be identified by
MALDI-MS.
The results obtained in 0%, 15%, and 25% (v/v) TFE are
summarized in Figure 4. In all conditions, preferential pro-
teolytic sites clustered within three regions of the protein,
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(A) Concentration of the peptide, determined spectrophotometrically after filtration with 0.02 mm filters, versus the peptide concentration before
filtration.
(B) Distribution of apparent hydrodynamic diameter for a solution containing 400 mM peptide, estimated by DLS.
(C) Far-UV CD spectra of the peptide at a concentration of 85 mM.
In all cases (A–C), the measurements were taken without (dashed line) or with (solid line) 20% (v/v) TFE, in 50 mM acetate (pH 5.5) at 25ºC.encompassing approximately residues 1–12, 44–61, and
83–91. These three regions of the sequence correspond,
in the native protein, to the unstructured N-terminal tail, to
the b hairpin formed by strands 2 and 3, and to b strand 4
plus a short segment of the following loop, respectively
(Figure 4). In native Sso AcP, b strands 2 and 3 occupy
internal position in the b sheet, while strand 4 is at one
edge of the sheet (Figure 1). The observation that the
pattern of proteolytic sites does not change significantly
with the addition of TFE is an indication that a preferential
solvent-exposure and/or chain flexibility is showed by
essentially the same stretches of the polypeptide chain
under the three sets of experimental conditions.
The Conversion of the Initial Aggregates
into Amyloid Protofibrils
In the light of the limited proteolysis results, several mu-
tants of Sso AcP were produced (Table 1). One mutant in-
volves a double substitution within the region 1–12 that
appears to be susceptible to proteolysis (V9A/F10A).
This mutant adds to the DN5, DN8, and DN11 deletion
variants described above. Six other variants involve
single substitutions of residues from the flexible region
44–61 (Y45A, K47A, and N48A) and 83–91 (V84A, Y86A,
and F88A). Two additional single-point mutants from
nonflexible regions were produced as controls (F29L
and I72V). All variants were incubated at a concentration
of 0.4 mg ml21 in 20% (v/v) TFE, 50 mM acetate buffer (pH
5.5), 25ºC. The conversion of the monomeric folded
structure into native-like enzymatically active aggre-
gates was followed by monitoring the change of [q]208and light scattering. The second step of aggregation
(the conversion of the initial aggregates into amyloid-
like protofibrils) was monitored by ThT fluorescence.
For simplicity, we shall describe the second step first.
The increase of ThT fluorescence followed apparent
single-exponential kinetics for most of the mutants, as
shown previously for the DN5 and DN8 variants (Fig-
ure 2A). The resulting rate constant, k2
ThT, was found for
nearly all mutants to be significantly different from that
of the wild-typeprotein, including the two control variants
F29L and I72V (Table 1). A statistically significant correla-
tion was found between the logarithm of k2
ThT and the
conformational stability in this group of protein variants
(the latter is expressed as the change of free energy
changeofunfolding,DDGU-F, asdetermined from GdnHCl
unfolding curves at equilibrium) (Figure 5A). The r and p
values (0.95 and <0.001, respectively) indicate that the
correlation is significant with all data points deviating by
less than 2 SD from the line of best fit (Figure 5A).
This relationship indicates that the conversion of indi-
vidual protein molecules from the native-like conforma-
tion adopted within the initial aggregates into that of the
amyloid protofibrils is a cooperative process. The accel-
eration of this process correlates with the extent of the
destabilization of the folded state induced by mutation
and the resulting ability of the protein to populate fully
or partially unfolded conformations that are competitive
for amyloid protofibril formation. In this mechanism, the
whole protein molecule undergoes a substantial struc-
tural reorganization. The mutation-induced acceleration
of this conversion is independent of the position of theFigure 4. Location of Proteolytic Sites Obtained for the Folded, Monomeric, Wild-Type Sso AcP
The three diagrams show the results obtained in 0%, 15%, and 25% (v/v) TFE with trypsin (blue), chymotrypsin (green), subtilisin (purple),
thermolysin (pink), elastase (yellow), and Glu-C (grey). In all cases, the proteolytic cleavage took place between the colored residue and the
following one in the sequence. Glu-C and thermolysin were not used in 15% and 25% (v/v) TFE because they were not active under these
conditions. The figure also shows the location of b strands and a helices along the sequence according to the X-ray structure (Corazza et al.,
2006) and the previously proposed algorithm (Kabsch and Sander, 1983).
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Mutant Cm (M)
a DDGU-F (kJ mol
21)b k1
CD (s21)c k1
LS (s21)c k2
ThT (s21)c
Wild-type 4.23 6 0.07 — 0.014 0.0174 0.0045
DN5 n.d. n.d. n.d. n.d. n.d.
DN8 4.59 6 0.07 4.0 6 1.7 0.0054 0.0055 0.00072
DN11 4.59 6 0.07 4.0 6 1.7 0.00005d 0.00005d —
V9A/F10A 4.45 6 0.07 2.45 6 1.6 0.0925 0.0084 0.0217
F29L 3.58 6 0.07 27.25 6 1.55 0.25 0.328 0.0572
Y45A 3.25 6 0.07 210.9 6 1.5 0.18 0.434 0.116
K47A 4.24 6 0.07 0.1 6 1.6 0.044 0.0819 0.00799
N48A 4.34 6 0.07 1.2 6 1.6 0.0179 0.0324 0.0116
I72V 3.78 6 0.07 25.0 6 1.6 0.079 0.0928 0.0111
V84A 3.20 6 0.07 211.5 6 1.5 0.034 0.065 0.111
Y86A 3.94 6 0.07 23.25 6 1.6 0.147 0.44 0.0117
F88A 2.92 6 0.07 214.6 6 1.5 0.11 0.11 0.183
All the experiments were performed in 20% (v/v) TFE, 50 mM acetate (pH 5.5) at 25ºC.
a The GdnHCl concentration required to unfold 50% of the protein molecules.
b Determined using the equation DDGU-F = <m> (C
0m2 Cm), where <m> is the average m value of all mutants (<m> = 11.14 + 0.20 kJ mol21 M21)
and Cm and C0m are the midpoint of denaturation for wild-type and mutant, respectively.
c Aggregation rate constants estimated by CD, LS and ThT analyses. Experimental uncertainties were 12%, 10% and 4% for k1
CD, k1
LS, and k2
ThT,
respectively.
d These values are not real estimates but experimental upper bonds.mutated site along the sequence and appears to depend
only on the magnitude of the destabilization of the overall
fold caused by the amino acid substitution.
No correlation was found between the observed
change of k2
ThT upon mutation and the change predicted
for the conversion of an unfolded state into amyloid-like
aggregates, determined on the basis of numerous pro-
posed algorithms (DuBay et al., 2004; Fernandez-Esca-
milla et al., 2004; Tartaglia et al., 2004; Chiti et al., 2003).
This indicates further that destabilization of the native-
like fold within the initial aggregate is a major factor
driving its conversion, compared to the establishment
of a specific b core within the subsequent amyloid-like
aggregates.
The Conversion of the Native-like Monomeric Protein
into the Initial Aggregates
The assembly into native-like aggregates from the mono-
meric folded state also occurs with different rates for the
various mutants investigated here (Table 1). However,
unlike the second step of aggregation, a correlation
between the logarithm of the aggregation rate constantdetermined with far-UV CD (k1
CD) or light scattering (k1
LS)
and conformational stability (DDGU-F) was only found
with some of the mutants from the flexible region 1–12
(DN8 and V9A/F10A), from the flexible region 44–61
(N48A, K47A, and Y45A), and with the two control mu-
tants (F29L and I72V).
All the three variants from the flexible region 83–91
(V84A, Y86A, and F88A) were found to have log(k1
CD)
and log(k1
LS) values that deviate by more than 2 SD
(p < 0.05) from the corresponding lines of best fit, i.e.,
from the values expected on the basis of only their con-
formational stability (Figures 5B and 5C, empty squares).
The DN11 mutant also deviates from the expected cor-
relation as the upper bound values of log(k1
CD) and
log(k1
LS) for this mutant are both remarkably distant
from the corresponding lines of best fit (Figures 5B and
5C, empty squares). This indicates that the flexible re-
gion 83–91, similarly to the unstructured N-terminal tail,
plays a key role in the first phase of aggregation of Sso
AcP that is detected here. For clarity, all the rate con-
stants defined here (k1
CD, k1
LS, and k2
ThT) do not have
any relationship with the lag phase as this is not detectedFigure 5. Aggregation Rates of Sso AcP Variants
Dependencies of the apparent rate constants for the formation of protofibrils as followed by using ThT fluorescence, k2
ThT (A), for the formation of
the initial aggregates as followed by using CD, k1
CD (B), and for the formation of the initial aggregates as followed by using light scattering, k1
LS
(C), on the change of conformational stability of Sso AcP upon mutation, DDGU-F. In all plots, filled circles and empty squares indicate values that
deviate by less and more than 2 SD from the corresponding lines of best fit, respectively. The log(k1
CD) and log(k1
LS) values of the DN11 mutant
are not real values but upper bonds of such values.
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conditions. In addition to having unusual values of k1
CD
andk1
LS, all three variants having mutations within the re-
gion 83–91 give rise to initial aggregates with CD spectra
that are significantly different from those of the wild-type
protein and all other variants (data not shown). This lends
further support to the idea that this region of the se-
quence plays a crucial role in this first aggregation step
of Sso AcP.
The presence of a correlation between k1
CD (or k1
LS)
and DDGU-F for all other variants and the finding that
the line of best fit has a slope similar to that observed
in the relationship between k2
ThT andDDGU-F (cf. Figures
5A, 5B, and 5C) suggests that the assembly of native-like
molecules into the initial aggregates requires a flexibility
of the folded state that correlates with its conformational
stability. This step does not require, however, full unfold-
ing because (1) this aggregation step is three orders of
magnitude more rapid than the global unfolding of the
nonaggregated protein under the same conditions, and
(2) the resulting aggregates preserve a residual native-
like topology as witnessed by the persistence of enzy-
matic activity (Plakoutsi et al., 2005). In the next para-
graph, we will show that in the folded state of Sso AcP
significant structural fluctuations occur more rapidly
than unfolding by three orders of magnitude.
The Folded Unit of Sso AcP Maintains a Native-like
Conformation Prior to Aggregation
The ability of DN11 Sso AcP to resist aggregation, under
conditions of TFE and pH in which the full-length protein
by contrast self-assembles, provides an opportunity to
investigate the structure, dynamics, and stability of the
globular unit of Sso AcP under conditions that promote
aggregation. The near-UV CD spectrum of DN11 Sso
AcP in 20% (v/v) TFE is very similar to that of the wild-
type protein in its absence, with a major positive peak
at ca. 270–280 nm in both cases (Figure 6A). The enzy-
matic activity of DN11 Sso AcP, determined as the rate
of catalysed hydrolysis of benzoylphosphate, decreases
linearly with TFE concentration, with the enzyme exhibit-
ing ca. 77% of the initial activity in 20% (v/v) TFE
(Figure 6B). The linear decrease, in the range of 0%–
50% (v/v) TFE, suggests that such reduction originates
from solvent effects rather than caused by a significant
structural transition. Incubation of the full-length protein
under the same conditions in 20% TFE leads to the for-
mation of initial aggregates and late protofibrils with en-
zymatic activities of ca. 63% and 0% of the correspond-
ing enzyme with no TFE (Figure 6B).
The conformational stability of DN11 Sso AcP in 20%
(v/v) TFE, studied by means of GdnHCl-induced equilib-
rium unfolding, is substantially lower than those of wild-
type and DN11 Sso AcP in 0% (v/v) TFE (Figure 6C).
Although unfolding of DN11 Sso AcP in 20% (v/v) TFE
occurs at a denaturant concentration (Cm) higher than
in its absence, the cooperativity of the former transition
is considerably lower, as indicated by a lower m value
(3.7 6 1.2 kJ mol21 M21 for DN11 Sso AcP in 20% [v/v]
TFE versus 11.14 6 0.20 kJ mol21 M21 for wild-type
and DN11 Sso AcP in 0% [v/v] TFE). The values of free
energy change of unfolding (DGU-F), that result from the
products of Cm and m values, are 22.6 6 7.3, 48.0 6
1.2, and 52.1 6 1.2 kJ mol21 for DN11 in 20% (v/v) TFE,wild-type in 0% (v/v) TFE, and DN11 Sso AcP in 0%
(v/v)TFE, respectively.
A shift of pH from 5.5 to 7.5 slows down considerably
the aggregation of the full-length protein in 15%–25%
TFE, allowing the conformational state adopted by Sso
AcP in the presence of TFE to be explored, albeit at a dif-
ferent pH. Full-length Sso AcP was incubated in the pres-
ence of 0% and 25% (v/v) deuterated TFE in 10 mM
ammonium acetate containing D2O rather than H2O, as
a solvent. In both conditions, the H/D exchange, quanti-
fied at regular time points by liquid chromatography
mass spectrometry (LCMS), is approximately a biphasic
process, with some of the atoms exchanging on a submi-
nute time scale and others exchanging on a slower time
scale of ca. 300 s (Figure 6D). However, it is clear that the
number of atoms exchanged during both phases is
higher in the presence of TFE than in its absence (Fig-
ure 6D). Importantly, the slower H/D exchange phase in
25% (v/v) TFE is more rapid than unfolding of the protein
under the same conditions by two orders of magnitude,
indicating that the H/D exchange occurs due to rapid
structural fluctuations rather than full unfolding of the
protein.
Overall, these data, along with the far-UV CD analysis
shown in Figure 2B, indicate that the globular unit of
Sso AcP maintains, under aggregating conditions but
before aggregation occurs, a secondary structure, pack-
ing around aromatic residues and positioning of resi-
dues in the catalytic site (Arg30, Asn48, and the loop
22GLVQGVG28) that are indistinguishable from those of
Figure 6. Properties of Native Monomeric Sso AcP under Condi-
tions Promoting Aggregation
(A) Near-UV CD spectra of wild-type Sso AcP in the absence of TFE
(filled circles) and of DN11 Sso AcP in 20% (v/v) TFE (empty circles).
Conditions were 50 mM acetate buffer (pH 5.5), 25ºC.
(B) Enzymatic activity of wild-type (filled circles) and DN11 (empty
circles) Sso AcP as a function of TFE concentration. Wild-type Sso
AcP was preincubated for 30 min under the indicated TFE concen-
trations before the measurements. The activity of the initial aggre-
gates formed from wild-type Sso AcP in 20% (v/v) TFE is also indi-
cated (empty square). The final protein concentration was in all
cases 0.0015 mg ml21 in 50 mM acetate buffer (pH 5.5), 25ºC.
(C) Equilibrium GdnHCl unfolding curves of wild-type Sso AcP with
no TFE (filled circles), DN11 Sso AcP with no TFE (empty triangles)
andDN11 Sso AcP in 20% TFE (empty circles). The fitting was based
on the two-state equation as described (Santoro and Bolen, 1988).
(D) Kinetic profiles for global H/D exchange of wild-type Sso AcP in
0% (filled circles) and 25% (empty circles) TFE at pH 7.5.
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999the protein under conditions in which it is stable in its
native state. In spite of this native-like structure, the
folded state of Sso AcP appears to be less stable and
more flexible in aggregating conditions than in fully
native conditions.
Discussion
In this work, we have investigated the mechanism by
which a globular protein in its fully folded state self-
assembles to form those amyloid protofibrils that are
increasingly recognized to represent the pathogenic
species in protein deposition diseases. The globular
unit of Sso AcP adopts initially, prior to aggregation, a na-
tive-like structure. Aggregation is promoted by region
1–12 (the unstructured N-terminal tail) and region 83–91
(approximately b strand 4) to form initial aggregates in
which the individual protein molecules retain characteris-
tics that are still reminiscent of the native state and far
from those of amyloid structures. This process does not
require full unfolding of the protein, as it occurs with
a rate that is three orders of magnitude higher than un-
folding under the same conditions (Plakoutsi et al.,
2004). However, it occurs more efficiently in the presence
of a solution medium in which the native state appears to
be less cooperatively folded and sufficiently flexible to
transiently exposemost of itsbackbone amides to hydro-
gen exchange with the solvent. In the presence of muta-
tions that destabilize the folded state, this native-like
assembly occurs more rapidly, lending further support
to the idea that local fluctuations are needed to promote
the process.
The rationale behind the involvement of the two regions
of the sequence 1–12 and 83–91 lies in the preferential
solvent exposure and/or flexibility of these two seg-
ments. The N-terminal tail, in particular, does not possess
any degree of secondary or long-range interactions and
is therefore the most susceptible region to nucleate ag-
gregation. The region 83–91 corresponds to one of the
two edge strands of the native b sheet of Sso AcP.
Edge b strands are so effective in promoting aggregation
of native structures that evolution has devised a number
of adaptations to prevent this phenomenon (Richardson
and Richardson, 2001). Region 44–61 also appears to
be solvent exposed and flexible. Nevertheless, since it
forms a b hairpin that is internal in the native b sheet of
Sso AcP (strands 2 and 3), it does not in fact promote
the assembly of native-like molecules.
Unlike the first step, the subsequent conversion of the
initial aggregates into amyloid protofibrils does not ap-
pear to be promoted by specific residues or regions of
the sequence. The effect of mutations on the rate of
this process does not depend on the position of the mu-
tated residues in the sequence or in the three-dimen-
sional fold but only on the extent by which the native
state appears to be destabilized. It therefore appears
to be a cooperative process that involves a global struc-
tural reorganization of each individual molecule from
a native-like fold into a nonnative amyloid-like conforma-
tion able to bind ThT, CR, and with extensive b sheet
structure.
The aggregation mechanism outlined here for Sso AcP
is distinct from that described previously for other globu-
lar proteins, which involve a significant unfolding of thenative globular state before structured aggregates can
form (Uversky and Fink, 2004). The first phase of Sso
AcP aggregation appears to require structural fluctua-
tions of the native state, but the resulting conformations
remain on the native side of the major free-energy barrier
of unfolding. The aggregation mechanism described here
for Sso AcP is also distinct from that proposed for pro-
teins with prion-like properties such as Sup35p and
Ure2p from S. cerevisiae and HET-s from P. anserina.
These proteins resemble Sso AcP as they are all charac-
terized by an unstructured tail, either at the N or C termi-
nus, and a folded domain. Models of fibril formation in
which the tails assemble autonomously to form the core
of the fibrils have been proposed for all prion systems
(Glover et al., 1997; Balguerie et al., 2003; Baxa et al.,
2003). In analogy with this idea, the unstructureddomains
can form amyloid-like fibrils in vitro and maintain a prion
status in vivo when dissected from their respective folded
domains (Masison and Wickner, 1995; Glover et al., 1997;
Kochneva-Pervukhova et al., 1998; Taylor et al., 1999;
Balguerie et al., 2003). In contrast to these models, the
N-terminal tail of Sso AcP remains fully soluble and mo-
nomericwhen isolated from the folded domain and needs
to interact with another portion of the protein to promote
aggregation of the full-length protein. In another study,
however, Ure2p was found to form fibrils in which the un-
structured tails interact with the folded domains, with the
latter maintaining a native-like conformation (Bousset
et al., 2002). This mechanism is similar to that proposed
here for the initial aggregates of Sso AcP.
The proposed mechanism, along with the increased
awareness that folded proteins retain a subtle but signif-
icant tendency to aggregate, has implications for our un-
derstanding of disease-related aggregation processes
in vivo, therapeutic treatment, and, more generally, po-
tentially harmful aggregation processes that may occur
physiologically and need to be actively combated by
living organisms.
Experimental Procedures
Materials
ThT, TFE, GdnHCl, urea, and D2O were purchased from Sigma-
Aldrich. Benzoylphosphate was synthesized and purified as de-
scribed (Camici et al., 1976). DNA oligonucleotides were purchased
from M-Medical (Milano, Italy). The mutated genes of Sso AcP were
created with the QuickChange Site-Directed Mutagenesis Kit from
Stratagene. The desired mutations were verified by DNA sequencing.
Sso AcP was expressed, purified, tested for purity, and stored as de-
scribed previously (Plakoutsi et al., 2004). The synthetic peptides
were purchased from Genscript Corporation and had amidated
C termini.
ThT Kinetics
Sso AcP and its variants were incubated in 20% (v/v) TFE, 50 mM ac-
etate buffer (pH 5.5), 25ºC, at a protein concentration of 0.4 mg ml21.
The experiments were performed as described (Plakoutsi et al.,
2004). The value of the ThT fluorescence intensity in the absence of
protein was subtracted from all the fluorescence measurements in its
presence, and the resulting values were normalized so that the final
fluorescence intensity at the endpoint of the kinetic trace was 100%.
Far-UV CD
Far-UV CD spectra were acquired at 25ºC with a Jasco J-810 spectro-
polarimeter (Tokyo, Japan) equipped with a thermostated cell holder
and a quartz cuvette of 1 mm path length. Wild-type and mutant Sso
AcPwere incubated ata concentrationof 0.4mg ml21 ineither 20%(v/
v) TFE, 50 mM acetate buffer (pH 5.5), or 0% TFE, 10 mM Tris (pH 8.0),
Structure
100025ºC. In another set of experiments, time-course measurements were
performed at 208 nm for 0.4 mg ml21 wild-type and mutant Sso AcP in
50 mM acetate buffer (pH 5.5), 25ºC, immediately after addition of
20% (v/v) TFE. The spectra of the 11 and 14 residue peptides were
acquired immediately after suspension in 0% (v/v) TFE and 30 min
after the addition of 20% (v/v) TFE at a concentration of ca. 85 mM
and 152 mM, respectively (conditions were 50 mM acetate buffer
[pH 5.5], 25ºC). In all cases, the spectra were blank subtracted and
normalized to mean residue ellipticity.
Dynamic Light Scattering
The 11 and 14 residue peptides corresponding to the N-terminal tail
of Sso AcP were suspended at a concentration of 400 mM in 50 mM
acetate (pH 5.5), 25ºC, in the presence and absence of 20% (v/v)
TFE. Size distributions by light scattering intensity were acquired
with a Zetasizer Nano S DLS device from Malvern Instruments
(Malvern, Worcestershire, UK). Low-volume 12.5 3 45 mm dispos-
able cuvettes were used. A Peltier thermostatting system maintained
the temperature at 25ºC. The viscosity and refractive index parame-
ters were set for each solution. The buffer and stock protein solutions
were centrifuged (18,000 rpm, 5 min) and filtered with 0.02mm Anotop
10 filters (Whatman, Maidstone, UK) before the measurements.
Solubility Assay of the Sso AcP Peptides
The lyophilized 11 and 14 residue peptides were dissolved in 0% or
20% (v/v) TFE, 50 mM acetate (pH 5.5), at concentrations ranging
from 50 to 400 mM, and were incubated for 30 min at 25ºC. The sam-
ples were then centrifuged (18,000 rpm, 5 min) and filtered (0.02 mm).
Peptide concentration was determined spectrophotometrically with
an Ultrospec 2000 spectrophotometer (Pharmacia Biotech, Cam-
bridge, UK) and a 1 mm path length quartz cuvette. The total peptide
concentration present before centrifugation and filtration was deter-
mined spectrophotometrically for each peptide with a solution
containing 150 mM peptide in 5 M urea, 10 mM Tris (pH 8.0), 25ºC.
Limited Proteolysis
Limited proteolysis experiments were carried out by incubating
20 mM Sso AcP with either trypsin, chymotrypsin, subtilisin, elastase,
endoprotease Glu-C, or thermolysin. Enzymatic digestions were all
performed in 20 mM Tris-HCl (pH 7.5), 25ºC, with enzyme-to-sub-
strate ratios ranging from 1/3000 to 1/20 (w/w). Enzymatic digestions
at different concentrations of TFE were carried out under the same
conditions in the presence of 15% and 25% (v/v) TFE with trypsin,
chymotrypsin, subtilisin, and elastase with enzyme-to-substrate
ratios ranging from 1/960 to 1/28 (w/w). The extent of the proteolytic
digestion was monitored on a time-course basis by sampling the
incubation mixture at different time intervals and directly analyzing
the released peptides by MALDI-MS. For each measurement, an
aliquot of 1 ml of peptide mixture was applied to a sample slide and
mixed with 5 ml of a 5 mg/ml sinapinic acid solution in acetonitrile/
0.2% TFA (70:30, v/v) before air drying. The samples were then
analyzed on a linear Voyager DE MALDI-TOF mass spectrometer
(Applied Biosystems, Foster City, CA). The mass range was internally
calibrated with the [M+H]+ and [M+H2]
2+ ions from the entire Sso AcP,
always present in the proteolytic mixture.
Equilibrium Unfolding
Samples of wild-type and mutated Sso AcP (8.5 mM) were incubated
for 1 hr in 50 mM acetate (pH 5.5), 37ºC, and different concentrations
of GdnHCl ranging from 0 to 6.8 M. The values of mean residue ellip-
ticity at 222 nm ([q]222) of the samples were measured with the same
CD apparatus and cuvette described above. The plot of [q]222 versus
GdnHCl concentration was fitted to a two-state transition equation,
as described (Santoro and Bolen, 1988), to determine the free energy
change upon unfolding in the absence of denaturant (DGU-F
H2O), the
dependence of DGU-F on GdnHCl concentration (m value), and the
midpoint of unfolding (Cm).
Near-UV CD
Near-UV CD spectra were acquired at 25ºC from 250 to 350 nm with
the Jasco J-810 spectropolarimeter and a 5 mm path length quartz
cuvette. The final protein concentration of the samples was 17 mM
(0.2 mg ml21). The spectrum of wild-type Sso AcP in 0% (v/v) TFE,
10 mM Tris (pH 8), 25ºC, and the spectrum of the DN11 Sso AcP in20% (v/v) TFE, 50 mM acetate buffer (pH 5.5), 25ºC, were recorded
as the average of 40 and 30 separate scans, respectively. The spectra
were blank subtracted and normalized to mean residue ellipticity.
Enzymatic Activity Measurements
DN11 Sso AcP was initially unfolded in 6 M GdnHCl, 50 mM acetate
(pH 5.5), 25ºC. The enzymatic activity was measured, as described
(Plakoutsi et al., 2004), immediately after diluting GdnHCl out and
adding different concentrations of TFE ranging from 0 to 46% (v/v).
The final protein concentration was 0.0015 mg ml21. The enzymatic
activity of the wt Sso AcP was evaluated in the presence of various
TFE concentrations with a 30 min preincubation under the same con-
ditions.
H/D Exchange
Two nanomoles of Sso AcP were dissolved in 50 ml of 10 mM ammo-
nium acetate (pH 7.5), 25ºC, for 5 min and then diluted into 450 ml of
the same buffer prepared with D2O (Sigma, Milan, Italy). The experi-
ment was repeated with deuterated 25% (v/v) in 10 mM ammonium
acetate buffer prepared in D2O. Sample aliquots for each time point
were loaded on a reverse-phase cartridge (Phenomenex widepore
C4, 4 3 2.0 mm) and eluted directly into the mass spectrometer ion
source at a flow rate of 200 ml/min with a fast desalting gradient. All
data were acquired in positive-ion mode with an LCMS system
including a triple quadrupole Quarttro Micro mass spectrometer
(Waters, Micromass, Manchester, United Kingdom) equipped with
an electrospray source interfaced with an Agilent 1100 HPLC system.
Source conditions (capillary, cone voltages, desolvation nitrogen
flow) were optimized for Sso AcP and used in all the experiments.
Mass spectra were acquired at time intervals ranging between 15 s
and 60 min, over the mass range 700–1400 m/z at a scan rate of
3 s/scan. The instrument was calibrated with myoglobin from horse
heart. Data processing parameters were the same for all spectra
(background subtraction, smoothing, and peak centroid). The total
number of exchangeable sites in any experiment was calculated by
the recorded molecular mass of Sso AcP on the basis of the theoret-
ical numbers of 99 exchangeable amide protons.
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